Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma

被引:7
作者
Zhou, Xueliang [1 ]
Dou, Mengmeng [2 ]
Liu, Zaoqu [1 ]
Jiao, Dechao [1 ]
Li, Zhaonan [1 ]
Chen, Jianjian [1 ]
Li, Jing [1 ]
Yao, Yuan [1 ]
Li, Lifeng [3 ]
Li, Yahua [1 ]
Han, Xinwei [1 ]
机构
[1] Zhengzhou Univ, Dept Intervent Radiol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China
关键词
LONG NONCODING RNA; CANCER; MICRORNAS; IDENTIFICATION; PROLIFERATION; METASTASIS; BIOMARKERS; APOPTOSIS; DIAGNOSIS; PATHWAYS;
D O I
10.1155/2021/5518908
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Hepatocellular carcinoma (HCC) remains an important cause of cancer death. The molecular mechanism of hepatocarcinogenesis and prognostic factors of HCC have not been completely uncovered. Methods. In this study, we screened out differentially expressed lncRNAs (DE lncRNAs), miRNAs (DE miRNAs), and mRNAs (DE mRNAs) by comparing the gene expression of HCC and normal tissue in The Cancer Genome Atlas (TCGA) database. DE mRNAs were used to perform Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. Then, the miRNA and lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a competitive endogenous RNA (ceRNA) network by weighted gene coexpression network analysis (WGCNA). Moreover, univariable Cox regression and Kaplan-Meier curve analyses of DE lncRNAs and DE mRNAs were conducted. Finally, the lasso-penalized Cox regression analysis and nomogram model were used to establish a new risk scoring system and predict the prognosis of patients with liver cancer. The expression of survival-related DE lncRNAs was verified by qRT-PCR. Results. A total of 1896 DEmRNAs, 330 DElncRNAs, and 76 DEmiRNAs were identified in HCC and normal tissue samples. Then, the turquoise miRNA and turquoise lncRNA/mRNA modules that were most closely related to the survival time of patients with HCC were screened to construct a ceRNA network by WGCNA. In this ceRNA network, there were 566 lncRNA-miRNA-mRNA regulatory pairs, including 30 upregulated lncRNAs, 16 downregulated miRNAs, and 75 upregulated mRNAs. Moreover, we screened out 19 lncRNAs and 14 hub mRNAs related to prognosis from this ceRNA network by univariable Cox regression and Kaplan-Meier curve analyses. Finally, a new risk scoring system was established by selecting the optimal risk lncRNAs from the 19 prognosis-related lncRNAs through lasso-penalized Cox regression analysis. In addition, we established a nomogram model consisting of independent prognostic factors to predict the survival rate of HCC patients. Finally, the correlation between the risk score and immune cell infiltration and gene set enrichment analysis were determined. Conclusions. In conclusion, the results may provide potential biomarkers or therapeutic targets for HCC and the establishment of the new risk scoring system and nomogram model provides the new perspective for predicting the prognosis of HCC.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma
    Zhang, Wenxia
    Fu, Qiang
    Yao, Kanyu
    ONCOLOGY LETTERS, 2020, 20 (04)
  • [32] A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients
    Fang, Shuang-Sang
    Guo, Jin-Cheng
    Zhang, Jian-Hua
    Liu, Jin-Na
    Hong, Shuai
    Yu, Bo
    Gao, Yuhan
    Hu, Su-Pei
    Liu, Hai-Zhong
    Sun, Liang
    Zhao, Yi
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (04) : 3569 - 3578
  • [33] Network of clinically-relevant lncRNAs-mRNAs associated with prognosis of hepatocellular carcinoma patients
    Lim, Lee Jin
    Jin, Yu
    Yang, Henry
    Chung, Alexander Y. F.
    Goh, Brian K. P.
    Chow, Pierce K. H.
    Chan, Chung Yip
    Blanks, William K.
    Cheow, Peng Chung
    Lee, Ser Yee
    Lim, Tony K. H.
    Chong, Samuel S.
    Ooi, London L. P. J.
    Lee, Caroline G.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [34] A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients
    Gao, Lei
    Xue, Juan
    Liu, Xiaomin
    Cao, Lei
    Wang, Ruifang
    Lei, Liangliang
    AGING-US, 2021, 13 (23): : 25453 - 25465
  • [35] Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
    Liu, Chunhua
    Wu, Simin
    Lai, Liying
    Liu, Jinyu
    Guo, Zhaofu
    Ye, Zegen
    Chen, Xiang
    BMC BIOINFORMATICS, 2023, 24 (01)
  • [36] Identification of a new risk score model based on hypoxia and EMT-related genes for predicting lung squamous cell carcinoma prognosis
    Zhuang, Xiaojie
    Yu, Shuang
    Yang, Shuren
    Chen, Jinping
    Feng, Jihong
    MEDICINE, 2023, 102 (44) : E35572
  • [37] PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma
    Cao, Lu
    Ma, Xiaoqian
    Zhang, Juan
    Yang, Cejun
    Rong, Pengfei
    Wang, Wei
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [38] PAXIP1 is regulated by NRF1 and is a prognosis-related biomarker in hepatocellular carcinoma
    Cheng, Qian
    Han, Xiao
    Xie, Hao
    Liao, Yan-Lin
    Wang, Fei
    Cui, Xiao-Ying
    Jiang, Chao
    Zhang, Cheng-Wan
    BIOMEDICAL REPORTS, 2025, 22 (03)
  • [39] Cellular senescence-related genes: predicting prognosis in hepatocellular carcinoma
    Weiwei Yuan
    Yuanmin Xu
    Zhiheng Wu
    Yang Huang
    Lei Meng
    Shiping Dai
    Songcheng Ying
    Zhangming Chen
    Aman Xu
    BMC Cancer, 23
  • [40] Identifying glycolysis-related LncRNAs for predicting prognosis in breast cancer patients
    Zou, Jiayue
    Gu, Yanlin
    Zhu, Qi
    Li, Xiaohua
    Qin, Lei
    CANCER BIOMARKERS, 2022, 34 (03) : 393 - 401